Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment

Stanczyk, Frank Z., Archer, David F., Bhavnani, Bhagu R.·2013·Contraception
DOI 10.1016/j.contraception.2012.12.011

Cites (268)

Items 201–259 of 259

  1. Hormones, Genes, And Cancer
    Brian E. Henderson, Bruce A.J. Ponder, Ronald K. Ross · 2003
  2. Low-dose Oral Contraceptives in Adolescents: How Low Can You Go?
    Holly Agostino, Giuseppina Di Meglio · 2010 · Journal of Pediatric and Adolescent Gynecology
  3. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea
    Hans-Joachim Ahrendt, Ulrich Karck, T Pichl, Thomas Mueller, Uwe Ernst · 2007 · The European Journal of Contraception & Reproductive Health Care
  4. CLINICAL TRIAL OF A NEW ORAL CONTRACEPTIVE PILL CONTAINING THE NATURAL OESTROGEN 17β‐OESTRADIOL
    B. Atedt, Sten Jeppsson, Percy Liedholm, Gunnar Rannevik, L Svanberg · 1979 · BJOG An International Journal of Obstetrics & Gynaecology
  5. Interindividual variation in the metabolism of ethynylestradiol
    Michael L'E. Orme, David J. Back, Simon E. Ball · 1989 · Pharmacology & Therapeutics
  6. Transport of Equine Estrogens: Binding of Conjugated and Unconjugated Equine Estrogens with Human Serum Proteins*
    Chee Chung Pan, C. Allan Woolever, BHAGU R. BHAVANI · 1985 · The Journal of Clinical Endocrinology & Metabolism
  7. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6β-hydroxycortisol
    Jürgen Hammerstein, Erhard Daume, A. Simon, Ulrich H Winkler, A. E. Schindler, David J. Back, Stephen Andrew Ward, Albrecht Neiß · 1993 · Contraception
  8. Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β‐estradiol in comparison to levonorgestrel/ethinylestradiol
    Terje Sørdal, Paul R Grob, Carole Verhoeven · 2012 · Acta Obstetricia Et Gynecologica Scandinavica
  9. Oral contraceptive containing natural estradiol for premenopausal women
    E Hirvonen, Hannu O. Allonen, Matti Pokela Vesa Anttila, Y. Kulmala, T. Ranta, Hilkka Rautiainen, P. Sipilä, Pekka Ylöstalo · 1995 · Maturitas
  10. 50 years of “The Pill”: celebrating a golden anniversary
    Anne Szarewski, Diana Mansour, LEE P. SHULMAN · 2010 · Journal of Family Planning and Reproductive Health Care
  11. Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism
    J.A. Gevers Leuven, Marianne C. Dersjant-Roorda, Frans M. Helmerhorst, Rinse de Boer, Angela Neymeyer-Leloux, Louis M. Havekes · 1990 · American Journal of Obstetrics and Gynecology
  12. Myocardial infarction, oral contraception, cigarette smoking, and coronary artery spasm in young women
    Bodh I. Jugdutt, Gerald F. Stevens, David J. Zacks, Simon J.K. Lee, Russell F. Taylor · 1983 · American Heart Journal
  13. Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: A double-blind, randomised, dose-finding pilot study
    Nathalie Chabbert‐Buffet, Didier Chassard, Edith Ochsenbein, Jean-Louis Thomas, Sophie Christin‐Maître · 2011 · The European Journal of Contraception & Reproductive Health Care
  14. Pharmacokinetics of ethynyloestradiol in humans.
    K. Fotherby · 1982 · PubMed
  15. Biogenesis of Estrogens by the Human Ovary
    Kenneth Joseph Ryan, Olive W. Smith · 1961 · Journal of Biological Chemistry
  16. Oral Contraceptive Use and Myocardial Infarction
    Diana B. Petitti, Stephen Sidney, Charles P. Quesenberry · 1998 · Contraception
  17. Drug Interactions Between Oral Contraceptives and Antibiotics
    Barry D. Dickinson, Roy Davis Altman, Nancy H. Nielsen · 2001 · Obstetrics and Gynecology
  18. The effect of triphasic oral contraceptives on plasma lipids and lipoproteins
    Wolfgang Patsch, Spencer A. Brown, Antonio M. Gotto, Ronald L. Young · 1989 · American Journal of Obstetrics and Gynecology
  19. NATURAL ŒSTROGENS FOR ORAL CONTRACEPTION
    Jørgen Vedelskov Serup, Erik Bostofte, S. Larsen, J. H. Westergaard, Paul Erik Lebech · 1979 · The Lancet
  20. Oral contraceptives and smoking, current considerations: Recommendations of a consensus panel
    Isaac Schiff, William R. Bell, Victoria Davis, Craig M. Kessler, Carole M. Meyers, Steven T. Nakajima, Brenda J. Sexton · 1999 · American Journal of Obstetrics and Gynecology
  21. Combined Oral Contraceptives and Antiretroviral PK/PD in Malawian Women: Pharmacokinetics and Pharmacodynamics of a Combined Oral Contraceptive and a Generic Combined Formulation Antiretroviral in Malawi
    Gretchen S. Stuart, Agnes Moses, Amanda Corbett, Grace Phiri, Wiza Kumwenda, Nkhafwire Mkandawire, Joseph Chintedze, Gabriel Malunga, Mina C. Hosseinipour, Myron S. Cohen et al. · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  22. Ovulation Inhibition with 17β‐Estradiol Cyclo‐Octyl Acetate and Desogestrel
    Werner Schubert, Göran Cullberg · 1987 · Acta Obstetricia Et Gynecologica Scandinavica
  23. A Case-Control Study of the Risk of Breast Cancer in Relation to Oral Contraceptive Use
    Lynn A. Rosenberg, Julie R. Palmer, E. Aileen Clarke, Samuel Shapiro · 1992 · American Journal of Epidemiology
  24. Oral Contraceptives and Survival in Breast Cancer Patients Aged 20 to 54 Years
    Katrina F. Trivers, Marilie D. Gammon, Page E. Abrahamson, Mary Jo Lund, Elaine W. Flagg, Patricia G. Moorman, Jay S. Kaufman, Jianwen Cai, Peggy L. Porter, Louise Annette Brinton et al. · 2007 · Cancer Epidemiology Biomarkers & Prevention
  25. Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs
    Alison M. Pack, Martha J. Morrell, Don J. McMahon, Elizabeth J. Shane · 2011 · Epilepsy & Behavior
  26. Plasma levels of ethinylestradiol (EE) during cyclic treatment with combined oral contraceptives
    Jean‐Marc Kaufman, Michel Thiéry, A. Vermeulen · 1981 · Contraception
  27. Blood pressure alters during the normal menstrual cycle
    Cecily C Kelleher, Caroline Martha Joyce, Gráinne A. Kelly, J. B. Ferris · 1986 · BJOG An International Journal of Obstetrics & Gynaecology
  28. New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women
    E Hirvonen, Ulf‐Håkan Stenman, M. Mälkönen, Vesa Rasi, E Vartiainen, Pekka Ylöstalo · 1988 · Maturitas
  29. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: A controlled comparative 12-month clinical trial
    Morris Notelovitz, Craig S. Kitchens, Farouk Y. Khan · 1992 · American Journal of Obstetrics and Gynecology
  30. Oral Contraceptive Use and Bone
    Shuying Wei, Tania Maree Winzenberg, Laura Louise Laslett, Alison Venn, Graeme Jones · 2010 · Current Osteoporosis Reports
  31. The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days
    Giorgy Csemiczky, Thom O. M. Dieben, Herjan J.T. Coelingh Bennink, B.-M. Landgren · 1996 · Contraception
  32. Urinary 2-Hydroxyestrone/16α-Hydroxyestrone Ratio and Family History of Breast Cancer in Premenopausal Women
    Giske Ursin, Stephanie J. London, Dongyun Yang, Chiu-Chen Tseng, Malcolm C. Pike, Leslie Bernstein, Frank Z. Stanczyk, Elisabet Gentzschein · 2002 · Breast Cancer Research and Treatment
  33. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    A. T. Teichmann · 1995 · PubMed
  34. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
    Jørgen Vedelskov Serup, Erik Bostofte, S Larsen, J. H. Westergaard · 1981 · PubMed
  35. Intermediates in the Transformation of Oral Estradiol
    Jack Fishman, Sarah Goldberg, Robert S. Rosenfeld, Barnett Zumoff, LEON HELLMAN, T. F. Gallagher · 1969 · The Journal of Clinical Endocrinology & Metabolism
  36. Estrogens and Antiestrogens I
    1999 · Handbook of experimental pharmacology
  37. Pharmacokinetics and Biotransformation of Estradiol Valerate in Ovariectomized Women
    B. Düsterberg, M. Schmidt‐Gollwitzer, M. Hümpel · 2008 · Hormone Research
  38. Plasma precursors of estrogen. III. Conversion of plasma dehydroisoandrosterone to estrogen in young nonpregnant women.
    Paul C. MacDonald, Clare D. Edman, Irwin J. Kerber, Pentti K. Siiteri · 1976 · PubMed
  39. Transdermal Hormonal Therapy in Perimenstrual Migraine: Why, When and How?
    Cristina Tassorelli, Rosaria Greco, Marta Allena, Erica Terreno, Rossella Elena Nappi · 2012 · Current Pain and Headache Reports
  40. EFFECTIVITY AND ACCEPTABILITY OF ORAL CONTRACEPTIVES CONTAINING NATURAL AND ARTIFICIAL ESTROGENS IN COMBINATION WITH A GESTAGEN
    Jørgen Vedelskov Serup, Erik Bostofte, S. Larsen, J. H. Westergaard · 1981 · Acta Obstetricia Et Gynecologica Scandinavica
  41. Qlaira®: a ‘natural’ change of direction
    Diana Mansour · 2009 · Journal of Family Planning and Reproductive Health Care
  42. Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyI estradiol on lipid metabolism in comparison with two levonorgestrel preparations
    Helenius J. Kloosterboer, Hans Rekers · 1990 · American Journal of Obstetrics and Gynecology
  43. The effect of the contraceptive pill on blood pressure: A randomized controlled trial of three progestogen-oestrogen combinations in Szeged, Hungary
    László Kovács, G. Bártfai, Gy. Apró, János Kristóf Annus, Christopher John Bulpitt, Elizabeth M. Belsey, A. Pinol, Task Force on Oral Contraceptives · 1986 · Contraception
  44. Why use of dienogest for the first contraceptive pill with estradiol?
    Alfred Otto Mueck, Harald Seeger, Kai J. Bühling · 2010 · Gynecological Endocrinology
  45. Effect of Age on Oral Contraceptive-Induced Venous Thrombosis
    Antonio Girolami, Luca Spiezia, Bruno Girolami, N. Zocca, Guido Luzzatto · 2004 · Clinical and Applied Thrombosis/Hemostasis
  46. The Relationship of Oral Contraception to Depressive Symptoms
    JOHN F. LEETON · 1973 · Australian and New Zealand Journal of Obstetrics and Gynaecology
  47. Hemostatic effects of smoking and oral contraceptive use
    Franca Fruzzetti · 1999 · American Journal of Obstetrics and Gynecology
  48. Estrogens and Antiestrogens II
    Michel Oettel, E. Schillinger · 1999 · Handbook of experimental pharmacology
  49. Oral contraceptives and risk of benign proliferative epithelial disorders of the breast
    Thomas E. Rohan, Kristan A. L'Abbé, Martin G Cook · 1992 · International Journal of Cancer
  50. Effect of oral contraceptives containing 20 and 35 μg ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers
    Frank Z. Stanczyk, Susan Ploszaj, Elisabet Gentzschein, Dajun Qian, Daniel R. Mishell · 1999 · Contraception
  51. The effect of transvaginal estradiol on bone in aged women: A randomised controlled trial
    Helena Salminen, Maria Sääf, Sven‐Erik Johansson, Hans G. Ringertz, Lars‐Erik Strender · 2007 · Maturitas
  52. Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial
    Ronald L. Young, Anthony DelConte · 1999 · American Journal of Obstetrics and Gynecology
  53. Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers
    Alfred Otto Mueck, Harald Seeger, Gudula Petersen, Ernst Schulte-Wintrop, Diethelm R. Wallwiener · 2001 · Contraception
  54. Biosynthesis, Transport, and Metabolism of Steroid Hormones
    Frank Z. Stanczyk, Philip M. Bretsky · 2003
  55. Hormones, genes, and cancer
    Lovell A. Jones · 2003 · Cancer
  56. Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives
    Anne‐Françoise Schlit, P. Grandjean, Jacques Donnez, Edith Lavenne · 1995 · Contraception
  57. Bioavailability of Four Oestradiol Suspensions with Different Particle-Sizes - In Vivo/In Vitro Correlation
    I. Kvorning, M. Strid Christensen · 1981 · Drug Development and Industrial Pharmacy
  58. Appearance of mammary cancers in male mice subjected to folliculin injections
    Lacassagne Ma · 1932
  59. Recent studies confirm the safety of oral contraceptives with respect to stroke.
    1996 · PubMed